Mallinckrodt
| Company type | Public |
|---|---|
| ISIN | IE00BBGT3753 |
| Industry | Pharmaceutical |
| Founded | 1867 |
| Headquarters |
|
Key people |
|
| Revenue | US$1.98 billion (2024) |
| US$90.2 million (2024) | |
| US$478 million (2024) | |
| Total assets | US$3.30 billion (2024) |
| Total equity | US$1.65 billion (2024) |
Number of employees | 2,700 (2024) |
| Website | mallinckrodt |
Mallinckrodt Pharmaceuticals plc is an Irish-American manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. In 2017, it had 5,500 employees and sales of $3.2 billion, of which $2.9 billion was from the U.S. healthcare system.
On August 1, 2025, it was announced that the firm had merged its operations with those of Endo.